Dr. Soliman Abdul Kader Fakeeh Hospital Co.

Total Valuation

Dr. Soliman Abdul Kader Fakeeh Hospital Co. carries a market capitalization of 8.29B, placing it among publicly traded companies globally. Its enterprise value stands at 9.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Dr. Soliman Abdul Kader Fakeeh Hospital Co. currently has 230.00M shares outstanding.

Valuation Ratios

Dr. Soliman Abdul Kader Fakeeh Hospital Co. trades at a trailing price-to-earnings ratio of 30.32. The price-to-sales ratio is 2.50, and the price-to-book ratio stands at 4.98.

Enterprise Valuation

On an enterprise value basis, Dr. Soliman Abdul Kader Fakeeh Hospital Co. trades at an EV/EBITDA multiple of 32.82 and an EV/FCF ratio of 11.21. The EV/Sales ratio of 2.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.82 provides insight into valuation relative to core operating earnings.

Financial Position

Dr. Soliman Abdul Kader Fakeeh Hospital Co. maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.24, indicating elevated leverage, while an interest coverage ratio of 4.91 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Dr. Soliman Abdul Kader Fakeeh Hospital Co. posts a return on equity of 17.51 and a return on invested capital of 5.21.

Taxes

Over the trailing twelve months, Dr. Soliman Abdul Kader Fakeeh Hospital Co. has paid 32.75M in income taxes, reflecting an effective tax rate of 13.67.

Stock Price Statistics

Dr. Soliman Abdul Kader Fakeeh Hospital Co.'s stock has declined approximately -12.85645% over the past 52 weeks. The 50-day moving average sits at 36.39, while the 200-day moving average is 35.97.

Income Statement

Over the trailing twelve months, Dr. Soliman Abdul Kader Fakeeh Hospital Co. generated 3.11B in revenue and converted that into 256.39M in net income, yielding earnings per share of 0.90. EBITDA reached 275.63M, while operating income came in at 275.63M.

Balance Sheet

Dr. Soliman Abdul Kader Fakeeh Hospital Co. holds 421.91M in cash and equivalents against 1.28B in total debt, resulting in a net debt position of 241.52M. Total book value stands at 1.56B, with working capital of 728.60M providing operational flexibility.

Cash Flow

Dr. Soliman Abdul Kader Fakeeh Hospital Co. produced 372.82M in operating cash flow over the past twelve months. After subtracting -385.59M in capital expenditures, free cash flow totaled -12.77M - equivalent to -0.06 per share.

Margins

Dr. Soliman Abdul Kader Fakeeh Hospital Co. operates with a gross margin of 21.44, reflecting its pricing power and cost economics. The operating margin of 8.85 and net profit margin of 8.24 provide insight into operational efficiency.

Dividends & Yields

Scores

Dr. Soliman Abdul Kader Fakeeh Hospital Co. posts an Altman Z-Score of 3.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.